Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome

Clinical and Experimental Dermatology

Volumn 30, Issue 6, 2005, Pages 702-706

  Sokolowska Wojdylo, M ^a,b   Wenzel, J ^a   Gaffal, E ^a   Steitz, J ^a   Roszkiewicz, J ^b   Bieber, T ^a   Tüting, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; CD7 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CUTANEOUS LYMPHOCYTE ANTIGEN; CYCLOPHOSPHAMIDE; DIPEPTIDYL PEPTIDASE IV; FLUDARABINE; GEMCITABINE; LYMPHOCYTE ANTIGEN; METHOTREXATE; PENTOSTATIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MONITORING; EARLY DIAGNOSIS; EXTRACORPOREAL PHOTOPHORESIS; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; LYMPHOCYTE CLONE; LYMPHOCYTE MIGRATION; PHOTOTHERAPY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEZARY SYNDROME; SKIN DISEASE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD26; ANTIGENS, CD4; ANTIGENS, CD7; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 27144538050     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01904.x     Document Type: Article

References (18)

1. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-71.
2. Washington LT, Huh YO, Powers LC et al. A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy. BMC Clin Pathol 2002; 2: 5.
3. Kamarashev J, Burg G, Kempf W et al. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol 1998; 25: 407-12.
4. Wojdylo M, Lenz J, Speuser P et al. Circulating CD4+ T cells in Sézary syndrome express CCR7 as well as CCR10 and may represent a malignant expansion of cutaneous 'central memory' T cells. Br J Dermatol 2005; 152: 258-64.
5. Jones D, Dang NH, Duvic M et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001; 115: 885-92.
6. Reinhold U, Abken H, Kukel S et al. CD7- T cells represent a subset of normal human blood lymphocytes. J Immunol 1993; 150: 2081-9.
7. Ferenczi K, Fuhlbrigge RC, Pinkus J et al. Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 2002; 119: 1405-10.
8. Ishida T, Utsunomiya A, Iida S et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 3625-34.
9. Vestergaard C, Bang K, Cesser B et al. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J Invest Dermatol 2000; 115: 640-6.
10. Teraki Y, Miyake A, Takebayashi R et al. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris. Clin Exp Dermatol 2004; 29: 658-63.
11. Wenzel J, Henze S, Wörenkämper E et al. Role of the chemokine receptor CCR4 and its ligand TARC/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus. J Invest Dermatol 2005; doi: 10.1111/ j.0022-202X.2005. 23755.x
12. Bernengo MG. Novelli M, Quaglino P et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 2001; 144: 125-35.
13. Kari L, Loboda A, Nebozhyn M et al. Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 2003; 197: 1477-88.
14. Buhling F, Kunz D, Reinhold D et al. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells. Nat Immun 1994; 13: 270-9.
15. Ikushima H, Munakata Y, Ishii T et al. Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci USA 2000; 97: 8439-44.
16. Ludwig A, Schiemann F, Mentlein R et al. Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J Leukoc Biol 2002; 72: 183-91.
17. Lambeir AM, Proost P, Durinx C et al. Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem 2001; 276: 29839-45.
18. Stanford MM, Issekutz TB. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. J Leukoc Biol 2003; 74: 791-9.